We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Fluidigm and Berkeley Lab Awarded Phase II STTR Grant to Develop Microfluidic Chip for in Situ Diffraction of Protein Crystals

News   Nov 29, 2006

 
Fluidigm and Berkeley Lab Awarded Phase II STTR Grant to Develop Microfluidic Chip for in Situ Diffraction of Protein Crystals
 
 
Advertisement
 

RELATED ARTICLES

A Look at How Psychedelics Bind to Serotonin Receptors

News

For the first time, scientists have solved the high-resolution structure of psychedelic compounds when they are actively bound to the 5-HT2A serotonin receptor on the surface of brain cells.

READ MORE

Collaborations Aim to Meet Unmet Clinical Needs in Biomarker Discovery and Characterization

News

Thermo Fisher Scientific announced agreements with AstraZeneca and the University of Nebraska Medical Center that will showcase new workflows to improve the throughput, robustness and standardization of clinical biomarker analysis.

READ MORE

Minimizing the Loss of Valuable Samples

News

A major collaborative effort has resulted in a significant technical advance in X-ray crystallographic sample strategies.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE